LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Hayes, Sally; O'Brart, David P.; Lamdin, Letitia S.; Doutch, James; Samaras, Kostas; Marshall, John; Meek, Keith Michael Andrew (2008)
Publisher: Elsevier
Languages: English
Types: Article
Subjects: RE

Classified by OpenAIRE into

mesheuropmc: sense organs, eye diseases, food and beverages, digestive, oral, and skin physiology, genetic structures
Purpose:\ud To evaluate the importance of complete epithelial removal before riboflavin–ultraviolet-A (UVA) corneal collagen crosslinking therapy.\ud \ud Setting:\ud School of Optometry and Vision Sciences, Cardiff University, Wales, United Kingdom.\ud \ud Methods:\ud Riboflavin eyedrops were applied at 5-minute intervals for 35 minutes to the anterior corneal surface of 36 porcine eyes (12 with no epithelial trauma but treated with tetracaine eyedrops, 12 with superficial epithelial trauma but with an intact basal epithelium, and 12 with a fully removed epithelium). The corneal surface of 6 tetracaine-treated eyes, 6 eyes with superficial epithelial trauma, and 6 eyes with a fully removed epithelium was exposed to UVA light for 30 minutes during riboflavin administration. The light transmission spectra of the enucleated corneas were analyzed with a spectrophotometer and compared with those of 9 untreated porcine corneas.\ud \ud Results:\ud Corneas with a fully removed epithelium treated with riboflavin showed an abnormal dip in the transmission spectrum between 400 nm and 510 nm (P<.01). This was attributed to the presence of riboflavin in the corneal stroma. The spectra of riboflavin-treated corneas with no epithelial trauma but tetracaine administration and those with superficial epithelial trauma did not differ from those of the non–riboflavin-treated controls. Exposure to UVA following riboflavin administration did not alter corneal light transmission.\ud \ud Conclusions:\ud Complete removal of the corneal epithelium is an essential component of riboflavin–UVA crosslinking therapy as superficial epithelial trauma and tetracaine administration alone are not sufficient to permit the penetration of riboflavin into the corneal stroma. Failure to achieve adequate stromal absorption of riboflavin may impair the efficacy of the crosslinking process.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Krachmer JH, Feder RS, Belin MW. Keratoconus and related noninflammatory corneal thinning disorders. Surv Ophthalmol 1984; 28:293-322
    • 2. Javadi MA, Motlagh BF, Jafarinasab MR, et al. Outcomes of penetrating keratoplasty in keratoconus. Cornea 2005; 24:941-946
    • 3. Reeves SW, Stinnett S, Adelman RA, Afshari NA. Risk factors for progression to penetrating keratoplasty in patients with keratoconus. Am J Ophthalmol 2005; 140:607-611
    • 4. Mamalis N, Anderson CW, Kreisler KR, et al. Changing trends in the indications for penetrating keratoplasty. Arch Ophthalmol 1992; 110:1409-1411
    • 5. Al-Yousuf N, Mavrikakis I, Mavrikakis E, Daya SM. Penetrating keratoplasty: indications over a 10 year period. Br J Ophthalmol 2004; 88:998-1001
    • 6. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope. Curr Opin Ophthalmol 2006; 17:356-360
    • 7. Wollensak G, Spoerl E, Seiler T. Stress-strain measurements of human and porcine cornea after riboflavin/ultraviolet-A-induced crosslinking. J Cataract Refract Surg 2003; 29:1780-1785
    • 8. Spo¨rl E, Schreiber J, Hellmund K, et al. Untersuchungen zur Verfestigung der Hornhaut am Kaninchen. [Cross-linking effects in the cornea of rabbits]. Ophthalmologe 2000; 97:203-206
    • 9. Spoerl E, Wollensak G, Seiler T. Increased resistance of crosslinked cornea against enzymatic digestion. Curr Eye Res 2004; 29:35-40
    • 10. Andley U. Photooxidative stress. In: Albert DM, Jakobiec FA, eds, Principles and Practice of Ophthalmology. Philadelphia, PA, Saunders, 1994; 575-590
    • 11. Wollensak G, Spoerl E, Wilsch M, Seiler T. Endothelial cell damage after riboflavin-ultraviolet-A treatment in the rabbit. J Cataract Refract Surg 2003; 29:1786-1790
    • 12. Spoerl E, Wollensak G, Dittert D-D, Seiler T. Thermomechanical behaviour of collagen cross-linked porcine cornea. Ophthalmologica 2004; 218:136-140
    • 13. Wollensak G, Spo¨ rl E, Seiler T. Riboflavin/ultraviolet-A-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol 2003; 135:620-627
    • 14. Spoerl E, Mrochen M, Sliney D, et al. Safety of UVA-riboflavin cross-linking of the cornea. Cornea 2007; 26:385-389
    • 15. Chan CCK, Sharma M, Boxer Wachler BS. Effect of inferiorsegment Intacs with and without C3-R on keratoconus. J Cataract Refract Surg 2007; 33:75-80
    • 16. Kostyuk O, Navolina O, Mubard TM, et al. Transparency of the bovine corneal stroma at physiological hydration and its dependence on concentration of ambient ion. J Physiol 2002; 543:633-642. Available at: http://jp.physoc.org/cgi/reprint/543/ 2/633. Accessed January 12, 2008
    • 17. Wollensak G, Wilsch M, Spoerl E, Seiler T. Collagen fiber diameter in the rabbit cornea after collagen-crosslinking by riboflavin/UVA. Cornea 2004; 23:503-507
    • 18. Kohlhass M, Spoerl E, Schilde T. Biomechanical evidence of the distribution of cross-links in corneas treated with riboflavin and ultraviolet A light. J Cataract Refract Surg 2006; 32:279-283 First author: Sally Hayes, PhD
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article